The goal of the Interdisciplinary Reproduction & Health Group (IRHG) Seminar Series is to highlight transdisciplinary precision research taking place in the reproductive health field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

The IRHG was organized and established through a faculty-driven, grass roots effort in 2016 to develop an integrative interdisciplinary program that transcends traditional departmental, college and system boundaries to foster excellence in reproduction, health research and education at Mizzou.

View all upcoming Reproductive Health events on the IRHG Seminar Series website.

For questions about this event, please reach out to Wipawee Winuthayanon.

"A Tour of Female Surgical Pathology in High Definition"

Speaker:
Mark Hunter, MD
Associate Professor of Obstetrics, Gynecology and Women's Health
MU School of Medicine

Director, Division of Gynecologic Oncology
MU Health Care

Date: Wednesday February 19, 2025, 4-5 p.m.

Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room

In-person and virtual option

• Light snack will be provided in person. All are welcome!

 Join The Zoom

About the Speaker

Hunter specializes in gynecologic oncology. With nearly twenty years in practice, he has expertise in the diagnosis and treatment of ovarian, uterine, cervical, vaginal and vulvar cancers.

In addition to his clinical practice, Hunter also works to advance medical technology. Many women who develop uterine cancer require a hysterectomy, a removal of the uterus. Traditionally, the surgery leaves a large scar and results in several weeks’ recovery time. Hunter has developed a prototype surgical device that would allow hysterectomies to be performed less invasively.

Hunter has also been an early adopter of new medical innovations. For many of his cancer patients, he operates using the da Vinci Surgical System. This advanced device decreases incision size and reduces complications — in many cases, enabling the patient to go home the same day.

Dr. Mark Hunter is an assistant professor in the School of Medicine and a gynecologic oncology specialist with MU Health. He also serves as director of gynecologic oncology at MU’s Ellis Fischel Cancer Center.